Skip to main content
. 2024 Feb 26;16(3):325. doi: 10.3390/pharmaceutics16030325
BCS Biopharmaceutics Drug Classification System
DSC differential scanning calorimetry
FDA Food and Drug Administration
HPLC high-performance liquid chromatography
IVM ivermectin
IVM-MCM ivermectin-loaded mesoporous silica particles
IVM-NC ivermectin-loaded poly-ε-caprolactone nanocapsules
MCM-41 mesoporous silica particles type hexagonal
MSN mesoporous silica nanoparticle
PBS phosphate buffer solution
PCL poly(ε-caprolactone)
PDI polydispersity index
PLGA poly(lactic-co-glycolic acid)
PM physical mixture
SLN solid lipid nanoparticles
TEM transmission electron microscopy
TGA thermogravimetric analysis
XRD X-ray diffraction